- Home
- MRNA vs BIP Comparison
MRNA vs BIP Comparison
Compare MRNA & BIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | BIP |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.5B | 16.3B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRNA | BIP |
|---|---|---|
| Price | $45.54 | $34.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 4 |
| Target Price | $34.27 | ★ $39.50 |
| AVG Volume (30 Days) | ★ 5.1M | 768.1K |
| Earning Date | 05-01-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 5.15% |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,263,000,000.00 | N/A |
| Revenue This Year | $9.36 | N/A |
| Revenue Next Year | $15.43 | $7.61 |
| P/E Ratio | ★ N/A | $39.22 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.28 | $29.19 |
| 52 Week High | $59.55 | $40.32 |
Technical Indicators
Market Signals| Indicator | MRNA | BIP |
|---|---|---|
| Relative Strength Index (RSI) | 34.72 | 34.58 |
| Support Level | $23.52 | $33.43 |
| Resistance Level | $55.36 | $35.23 |
| Average True Range (ATR) | 2.76 | 0.85 |
| MACD | -0.87 | -0.13 |
| Stochastic Oscillator | 7.99 | 29.13 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About BIP Brookfield Infrastructure Partners LP
Brookfield Infrastructure Partners LP is a Bermuda exempted limited partnership that owns and operates quality, long-life assets that generate stable cash flows, by virtue of barriers to entry or other characteristics that tend to appreciate in value over time. It focuses on acquiring infrastructure assets that have low maintenance capital costs and high barriers to entry. The company's segments consist of Utilities, Transport, Midstream, and Data. Geographically, it generates maximum revenue from USA and also has a presence in Australia, Colombia, United Kingdom, Brazil, United States of America, Chile, Peru, and other countries.